INS and type 2 diabetes mellitus: The same observation was also reported by Hu and coworkers; 32% of the T2DM patients who received WJ-MSC transplantation became insulin-free within a period ranging from 3 to 11 months after receiving WJ-MSC infusion and remained insulin-free for a mean period of 12.5 ± 6.8 months [36].